Use este identificador para citar o ir al link de este elemento: http://hdl.handle.net/1843/61859
Tipo: Artigo de Periódico
Título: Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil
Autor(es): Mariana Lourenço Freire
Daniel Moreira Avelar
Glaucia Fernandes Cota
Lindicy Leidicy Alves
Carolina Senra de Souza
Juliana Wilke Saliba
Verônica Faria
Mariana Junqueira Pedras
Nara de Oliveira Carvalho
Gláucia Queiroz Andrade
Ana Rabello
Resumen: A rapid and accurate diagnosis is a crucial strategy for containing the coronavirus disease (COVID-19) pandemic. Considering the obstacles to upscaling the use of RT–qPCR, rapid tests based on antigen detection (Ag-RDT) have become an alternative to enhance mass testing, reducing the time for a prompt diagnosis and virus spreading. However, the performances of several commercially available Ag-RDTs have not yet been evaluated in several countries. Here, we evaluate the performance of eight Ag-RDTs available in Brazil to diagnose COVID-19. Patients admitted to tertiary hospitals with moderate or mild COVID-19 symptoms and presenting risk factors for severe disease were included. The tests were performed using a masked protocol, strictly following the manufacturer’s recommendations and were compared with RT–qPCR. The overall sensitivity of the tests ranged from 9.8 to 81.1%, and specificity greater than 83% was observed for all the evaluated tests. Overall, slight or fair agreement was observed between Ag-RDTs and RT–PCR, except for the Ag-RDT COVID-19 (Acro Biotech), in which moderate agreement was observed. Lower sensitivity of Ag-RDTs was observed for patients with cycle threshold > 25, indicating that the sensitivity was directly affected by viral load, whereas the effect of the disease duration was unclear. Despite the lower sensitivity of Ag-RDTs compared with RT–qPCR, its easy fulfillment and promptness still justify its use, even at hospital admission. However, the main advantage of Ag-RDTs seems to be the possibility of increasing access to the diagnosis of COVID-19 in patients with a high viral load, allowing immediate clinical management and reduction of infectivity and community transmission.
Asunto: Testes de Diagnóstico Rápido
Teste para COVID-19
Brasil
Idioma: eng
País: Brasil
Editor: Universidade Federal de Minas Gerais
Sigla da Institución: UFMG
Departamento: HCL - HOSPITAL DAS CLINICAS
MEDICINA - FACULDADE DE MEDICINA
Tipo de acceso: Acesso Aberto
Identificador DOI: https://doi.org/10.1371/journal. pone.0269997
URI: http://hdl.handle.net/1843/61859
Fecha del documento: 16-jun-2022
metadata.dc.url.externa: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269997
metadata.dc.relation.ispartof: Plos One
Aparece en las colecciones:Artigo de Periódico

archivos asociados a este elemento:
archivo Descripción TamañoFormato 
Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil.pdf5.64 MBAdobe PDFVisualizar/Abrir


Los elementos en el repositorio están protegidos por copyright, con todos los derechos reservados, salvo cuando es indicado lo contrario.